LEXINGTON, Mass. (AP) -- Biotechnology company Epix Pharmaceuticals Inc. said Monday Chief Executive Dr. Michael G. Kauffman resigned to pursue other interests.
Kauffman, who also resigned as a director, has been with Epix since August 2006, when it bought Predix Pharmaceuticals Holdings, where he had been serving as CEO since 2002.
Elkan Gamzu will take over as interim CEO, effective immediately. He has been working as a consultant to the biotechnology and pharmaceutical industries.